The judge overseeing the $212.5 million settlement in three toxic foam class actions against the Commonwealth of Australia has been told of at least one objection to the deal and has flagged difficulties taking submissions from opposing group members at an upcoming approval hearing.
A fight to lead a class action against Monsanto over its allegedly cancer-causing weedkiller Roundup is on foot, with a third class action soon to be filed against the chemical giant.
The Federal Court has updated guidance on its response to the coronavirus outbreak, saying it is working with lawyers to ensure as many hearings listed for the coming months can proceed. And Monday’s calendar, while perhaps lighter than usual, shows multiple matters will be heard as planned — by telephone.
Three Sydney-based law firms are now facing claims by Australian-Chinese investors seeking over $6 million in damages for allegedly negligent advice provided about investment properties developed by the now collapsed Ralan Group.
A class action seeking almost $2 million in damages has been launched on behalf of Australian-Chinese investors against a Sydney law firm over advice on investment properties sold by the now collapsed developer Ralan Group.
The Federal Government will pay $212.5 million to settle three class actions over the use of allegedly toxic firefighting foam at government military bases.
Venture capitalist Elaine Stead is pushing forward with her defamation case against the Nine-owned Fairfax Media despite what she has called an “inadequate” third attempt at a defence by the publisher.
Litigation funder Augusta Ventures has had its appeal of a groundbreaking ruling that put it on the hook for security for costs in a Fair Work class action pushed back by three months after a delayed case management hearing, with a Federal Court judge telling the parties they were to blame.
An individual claimant accusing AMP Financial Planning of ignoring multiple attempts to gain remediation for alleged insurance re-writing conduct was granted permission to voice his displeasure in court, while ASIC and AMP grapple with the details of a remediation program for insurance churn victims.
Medtronic owned Covidien and two other medical device manufacturers have been hit with a class action on behalf of thousands of women who claim to have suffered lifelong complications from the devices, the third class action over pelvic mesh implants brought in Australia.